The analysis of sPD-1 and sPD-L1 levels in ovarian cancer patients showed that serum sPD-1 levels were not significantly associated with any clinicopathological characteristics, including age, tumor histology, stage, size, nodal status, metastasis, or grade. This evidence concerns the gene HOXD13 and neoplasm.